1912
J . Org. Chem. 1997, 62, 1912-1913
New Ap p r oa ch to th e Ster oid BCD-Rin g
System Usin g Ta n d em Ra d ica l Cycliza tion
Takashi Takahashi,* Satoshi Tomida,
Yasuharu Sakamoto, and Haruo Yamada
Department of Chemical Engineering, Tokyo Institute of
Technology, 2-12-1 Ookayama, Meguro, Tokyo 152, J apan
Received December 20, 1996
Syntheses of polycyclic skeletons, such as steroids and
terpenes, have a central place in the development of
regio- and stereochemically controlled synthetic meth-
odology.1 The elaboration of ring-fused carbocycles based
upon “tandem cyclizations” such as cation cyclization,2
radical cyclization,3 and tandem Heck cyclization4 offer
efficient methods for the rapid and stereocontrolled
synthesis of polycyclic skeletons. We have developed
efficient approaches to the steroid CD ring based upon
the double Michael reaction,5 sequential Claisen rear-
rangement,6 and Pd-catalyzed cyclization.7 We have also
described a unique synthesis of the steroid ABC ring
system using a transannular Diels-Alder reaction.8
Recently, a tandem radical cyclization using an acyl
radical intermediate to synthesize the steroid skeleton
(A f B f C f D) has been reported.9 We report here
an alternative approach (D f C f B) to the steroid BCD-
ring 4 using a “tandem radical cyclization”,10 with a view
toward the syntheses of progesterone (1), 11R-hydroxy-
progesterone (2), a key intermediate for hydrocortisone,
and Proscar (3),11 an inhibitor of enzyme human prostatic
5R-reductase (Figure 1).
F igu r e 1. Retrosynthesis of 4 and tandem radical cyclization
giving 5.
In our synthetic plan (Figure 1), acyclic iodide 7 is the
key intermediate for the tandem radical cyclization,
which involves the first cyclization to generate the D-ring
via a 5-exo-trig closure (7 f 6) and the subsequent second
cyclization to provide the C-ring via a 6-exo-trig closure
(6 f 5). Cyclization of the B ring in 5 using an acyl
anion, followed by a base-induced isomerization of the
resulting cyclized product, should provide the stable
10R,17â-BCD ring 4.12,13 It is well known that 5-exo-trig
F igu r e 2. Flexible reactant models of the tandem radical
cyclization.
cyclizations are generally preferred over 6-endo-trig
closures, and introduction of an activating group on the
alkene terminus accelerates 6-exo-trig cyclization.3d,14
Thus, the regiochemical outcome of the cyclization would
be directed to give the desired steroid CD ring system.
However, it is still difficult to predict the stereochemical
outcome of the acyclic radical cyclizations of 7 because
of the many conformational possibilities and relative
stereochemistry between the C(13)-methyl and C(17)
methyl ketone. For the quantitative modeling of the
radical cyclization of 7, the MM2 transition-state model15
(flexible reactant model) was applied to the tandem
radical cyclizations of 17â-8 and 17R-8 (t-BuMe2SiO
group is replaced by a hydrogen; see Figure 2). On the
basis of the assumption of a stepwise process for this
tandem radical cyclization, we constructed MM2 transi-
tion-state structures for all possible ring closures by using
Monte Carlo (MC) random-search16 to find the initial
structures. The extended MM2* force field17 and Houk’s
radical cyclization parameters18 were applied to minimize
the energies. MM2 calculations and a Boltzmann dis-
(1) Blickenstaff, R. T.; Ghosh, A. C.; Wolf, G. C. Total Synthesis of
Steroids; Academic: New York, 1974.
(2) For a review see: (a) J ohnson, W. S. Bioorg. Chem. 1976, 5, 51-
98. (b) Taylor, S. K. Org. Prep. Proc. Int. 1992, 24, 247-284.
(3) For recent reviews: (a) Stork, G. In Current Trends in Organic
Synthesis; Nozaki, H., Ed.; Pergamon: Oxford, 1983; p 359. (b) Giese,
B. Radicals in Organic Synthesis: Formation of Carbon-Carbon
Bonds; Pergamon: Oxford, 1986. (c) J asperse, C. P.; Curran, D. P.;
Fevig, T. L. Chem. Rev. 1991, 91, 1237-1286. (d) Curran, D. P. In
Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Semmel-
hack, M. F., Ed.; Pergamon: Oxford, 1991; Vol. 4, p 779.
(4) Negishi, E.; Coperet, C.; Ma, S.; Liou, S.-Y.; Liu, F. Chem. Rev.
1996, 96, 365-393.
(5) (a) Takahashi, T.; Naito, Y.; Tsuji, J . J . Am. Chem. Soc. 1981,
103, 5261-5263. (b) Takahashi, T.; Okumoto, H.; Tsuji, J .; Harada,
N. J . Org. Chem. 1984, 49, 948-950.
(6) (a) Takahashi, T.; Yamada, H.; Tsuji, J . J . Am. Chem. Soc. 1981,
103, 5259-5261. (b) Takahashi, T.; Yamada, H.; Tsuji, J . Tetrahedron
Lett. 1982, 23, 233-234.
(7) Takahashi, T.; Miyazawa, M.; Ueno, H.; Tsuji, J . Tetrahedron
Lett. 1986, 27, 3881-3884.
(13) Throughout this manuscript, steroid numbering is used for
convenience, even when the intermediates do not have a steroid
skeleton.
(8) (a) Takahashi, T.; Shimizu, K.; Doi, T.; Tsuji, J .; Fukazawa, Y.
J . Am. Chem. Soc. 1988, 110, 2674-2676. (b) Takahashi, T.; Sakamoto,
Y.; Doi, T. Tetrahedron Lett. 1992, 33, 3519-3522.
(14) Beckwith, A. L. J .; Moad, G. J . Chem. Soc., Chem. Commun.
1974, 472-473.
(9) (a) Chen, L.; Gill, G. B.; Pattenden, G. Tetrahedron Lett. 1994,
35, 2593-2596. (b) Batsanov, A.; Chen, L.; Gill, G. B.; Pattenden, G.
J . Chem. Soc., Perkin. Trans. 1 1996, 45-55. (c) Zoretic, P. A.; Chen,
Z.; Zhang, Y. Tetrahedron Lett. 1996, 37, 7909-7912.
(10) Takahashi, T.; Katouda, W.; Sakamoto, Y.; Tomida, S.; Yamada,
H. Tetrahedron Lett. 1995, 36, 2273-2276.
(15) Eksterowicz, J . E.; Houk, K. N. Chem. Rev. 1993, 93, 2439-
2461.
(16) Chang, G.; Guida, W. C.; Still, W. C. J . Am. Chem. Soc. 1989,
111, 4379-4386.
(17) All modeling calculations reported in this paper were carried
out using MacroModel V.4.0 software. Mohamadi, F.; Richards, N. G.
J .; Guida, W. C.; Liskamp, R.; Lipton, M.; Caufield, C.; Chang, G.;
Hendrickson, T.; Still, W. C. J . Comput. Chem. 1990, 11, 440-467.
(11) Prous, J .; Castaner, J . Drugs. Future 1991, 16, 996-1000.
(12) For the isomerization of 20-ketopregnanes see: Rubin, M. B.
Steroids 1963, 2, 561-581.
S0022-3263(96)02388-2 CCC: $14.00 © 1997 American Chemical Society